Scott Mulhauser/Erin Shields
Baucus Headed to China to Discuss Currency, Ways to Increase American Competitiveness
Finance Chairman to Meet with Top Chinese Officials on Key Economic, Trade Issues
Washington, DC – Senate Finance Committee Chairman Max Baucus (D-Mont.) announced today that he will travel to China the week of October 10 to discuss key economic and trade issues, including China’s currency practices, with top Chinese officials.
“China’s currency undervaluation hurts American ranchers and farmers, American exports and American jobs. I have long said that China must take meaningful action to address its currency practices and we must be vigilant in pushing China on this issue,” Baucus said. “This trip will provide the opportunity to discuss China’s currency manipulation and other key economic and trade issues with top Chinese officials to find solutions in the best interest of both of our economies.”
Baucus will visit Beijing and Shanghai, where he will meet with Chinese government leaders and tour Chinese green technology companies as well as innovative American companies with research hubs in China. He will focus on finding ways to increase U.S. exports, which creates jobs here at home. Baucus will also examine ways to make the United States more competitive in the global market, including improving China’s protection of U.S. intellectual property rights and addressing concerns about China’s policies to promote domestic Chinese or “indigenous” innovative products. Baucus will also push China to further open its market to American agricultural exports, including world-class Montana beef and wheat.
Baucus has long fought for a robust trade agenda that supports American jobs through strong enforcement of our current agreements and an aggressive pursuit of new markets. The Finance Committee has jurisdiction over U.S. trade policy.
Next Article Previous Article
- Grassley, Daines, McSally Introduce Elder Justice Legislation to Boost Programs, Help Fight COVID in Nursing Homes
- Grassley Introduces the Updated Prescription Drug Pricing Reduction Act of 2020
- Grassley, Colleagues Introduce Updated Bipartisan Prescription Drug Pricing Bill
- Grassley on Responses to Economic Effects of COVID-19, Including Relief to States and Localities
- Grassley Discusses USMCA on Fox Business Network